1LUBBE A S, ALEXIOU C, BERGEMANN C. Clinical Application of Magnetic Drug Targeting[J]. Surg Res, 2001,95(2): 200 -206.
2EMBLETON M J. Drug Targeting by Monoclonal Antibodies [J]. Br J Cancer, 1987,55(3) :227 -231.
3BRODESKY F M. Monoclonal Antibodies As Magic Bullets [J]. Pharm Res,1988,5(1) :1 -9.
4TORCHILIN V P. Drug Targeting [ J ]. Eur J Pharm Sci,2000,11 (2) :81 -91.
5ZAHIRUL M,KHAN I,PREBEG Z,et al. A Ph -dependent Colon Targeted Oral Drug Delivery System Using Methacrylic Acid Copolymers [ J ]. Controlled Release, 1999,58:215 - 222.
6WEINSTEINJN, MAGINRL,YATVINMB,etal. Liposomes and Local Hyperthermia:Selective Delivery of Methotrexate to Heated Tumors[J]. Science ,1979 ,204 :188 - 191.
7WIDDER K J, SENYEI A E. Intravascularly Administrable,Magneitically Localizable Biodegradable Carrier [ P ]. U. S:4247406,1981.
8MINAMIMURA T, SATOH, KASAOKAS, etal. Tumor Regression Inductive Hyperthermia Combined with Hepatic Embolization Using Dextram Magnetite- incorporated Microspheres in Rats[J].Int J Oncol,2000,16(6):1 156-1 158.
9ILLUM L. Chitosan and It's Use as a Pharmaceutical Excipient[J]. Pharm Res,1998,15(9) :1 326- 1 331.
10GOODWIN S C, BITTNER C A, PETERSON C L, et al.Single - dose Toxicity Study of Hepatic Intra - arrerial Infusion of Doxorubicin Coupled to a Novel Magnetically Targeted Drug Carrier [ J ]. Toxicol Sci, 2001,60 ( 1 ): 177 - 183.
